Are There Any Cardioprotective Effects or Safety Concerns of Erythropoietin in Patients With Myocardial Infarction? A Systematic Review

Myocardial infarction (MI) is a global cause of morbidity and mortality. MI is the outcome of a chronic process termed atherosclerosis, a buildup of fatty and other substances called plaques inside the coronary vessels, causing hardening and thickening of the arterial wall. Erythropoietin (EPO) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jean-Baptiste, Wilford, Yusuf Ali, Amina, Inyang, Bithaiah, Koshy, Feeba Sam, George, Kitty, Poudel, Prakar, Chalasani, Roopa, Goonathilake, Mastiyage R, Waqar, Sara, George, Sheeba, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255911/
https://www.ncbi.nlm.nih.gov/pubmed/35812547
http://dx.doi.org/10.7759/cureus.25671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255911/
https://www.ncbi.nlm.nih.gov/pubmed/35812547
http://dx.doi.org/10.7759/cureus.25671

Ejemplares similares